Amgen Expects FY23 Adjusted EPS Of $18.20-$18.80 Versus Prior Guidance Of $17.80-$18.80 And Consensus Of $18.26
Portfolio Pulse from Benzinga Newsdesk
Amgen has updated its FY23 adjusted EPS guidance to $18.20-$18.80, compared to its previous guidance of $17.80-$18.80 and consensus of $18.26.
October 31, 2023 | 11:19 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Amgen's revised FY23 adjusted EPS guidance is higher than its previous guidance, which could be seen as a positive signal by investors.
Amgen's revised FY23 adjusted EPS guidance is higher than its previous guidance. This indicates that the company expects to perform better than previously anticipated, which could be seen as a positive signal by investors and could potentially lead to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100